PD-1/PD-L1 monoclonal antibody
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PD-1/PD-L1 monoclonal antibody, covering 2025-07-02 to 2025-12-08. Get the full timeline:
Most recent: Clinical Trial Update: LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer [Phase 1, Phase 2]